TMCnet News
LexisNexis Certified by SAFE-BioPharma Association [Health & Beauty Close - Up](Health & Beauty Close - Up Via Acquire Media NewsEdge) LexisNexis Risk Solutions has been certified by the U.S. government-approved Trust Framework Provider, SAFE-BioPharma Association. LexisNexis reported that this certification means that identity credentials can be trusted and used at known levels of assurance by U.S. federal agencies, such as the Department of Veterans Affairs, National Institutes of Health and Food and Drug Administration. On Friday, the White House issued an Executive Order, directing the government to lead by example in securing transactions and sensitive data. "In today's environment where we must be vigilant in safeguarding information, we support the Executive Order's charge 'to ensure that all agencies making personal data accessible to citizens through digital applications require the use of multiple factors of authentication and an effective identity proofing process,'" said Kim Little Sutherland, Senior Director, Identity Management, LexisNexis. "This accreditation offers our customers further peace of mind that LexisNexis manages sensitive information with the same level of care and diligence that they would expect for an agency of the federal government. It also demonstrates LexisNexis capabilities in identity management and multi-factor authentication to enable secure consumer relationships with their health care organizations and government agencies." According to a company release, as an Identity Proofing Component Member, LexisNexis has satisfied all requirements for Identity Proofing at the National Institute of Standards and Technology (NIST) Levels 1, 2, and 3 under the Federal Identity, Credential & Access Management (FICAM) Trust Framework Provider 1.0 program. LexisNexis has been authorized up to the third Level of Assurance, which adds cryptographic strength mechanisms and authentication procedures to guard the authentication token against compromise. The scope of the accreditation covers the LexisNexis Instant Authenticate and Multi-Factor Authentication solutions, which ensure issuing authorization and access privileges for authorized recipients and offer scalable authentication procedures in accordance with NIST Levels of Assurance. Also included in this accreditation are the LexisNexis InstantID and InstantID Q&A solutions, identity verification and identity fraud prevention systems that offer scalable security comparable to the difference between NIST levels 1 and 3. SAFE-BioPharma manages the SAFE-BioPharma global digital identity and digital signatures standard, developed for and used throughout the biopharmaceutical industry. LexisNexis Risk Solutions is a provider of information that helps customers across all industries and government assess, predict and manage risk. LexisNexis Risk Solutions is part of Reed Elsevier, a provider of professional information solutions. More information and complete details: www.safe-biopharma.org www.lexisnexis.com/risk ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |